RESUMEN

Thymic stromal lymphopoietin (TSLP), an interleukin 7-like cytokine, can trigger dendritic cell (DC)-mediated T-helper type 2 (Th2) inflammatory responses. Recent evidence demonstrates that cytokines TSLP and OX40 (CD134)/OX40 ligand seem to be important players in the maintenance of Th2 memory pool in the pathogenesis of asthma. Accumulating data reveal that the pathogenic T cells involved in asthma are likely to be inflammatory Th2 cells. TSLP is involved in the development of asthma through crosstalk with nuclear factor NF-ĸB. Progression of skin fibrosis in atopic dermatitis occurs via TSLP/TSLP receptor. TSLP-mediated dermal inflammation aggravates experimental allergic asthma. Also, TSLP polymorphisms are associated with susceptibility to asthma, atopic dermatitis, and eczema herpeticum. These findings suggest a master switch of TSLP in the initiation of allergic and adaptive inflammation through innate pathways at the epithelial cell-DC interface. The TSLP pathway is therefore a promising target for immunotherapy of allergic diseases.

Asunto(s)

Asma/inmunología , Citocinas/inmunología , Citocinas/metabolismo , Células Dendríticas/inmunología , Hipersensibilidad/inmunología , Células Th2/inmunología , Animales , Asma/metabolismo , Asma/terapia , Citocinas/genética , Humanos , Hipersensibilidad/metabolismo , Hipersensibilidad/terapia , Inflamación/inmunología , Mediadores de Inflamación/inmunología , Ligando OX40/inmunología , Ligando OX40/metabolismo , Linfopoyetina del Estroma Tímico

RESUMEN

Over the last few years, a significant progress has been made in understanding of the genetic basis of asthma. This has led to the identification of several chromosomal regions and loci showing linkage to and association with asthma and asthma-linked phenotypes. Recent positional cloning approaches have also been informative in identifying several strong candidate genes for asthma. The next challenge will involve validation of these findings and, importantly, identification of the functional basis in the pathophysiology of asthma. This review will describe the power of positional cloning for the identification of asthma genes, highlight the functional importance of the genetic variants, and address the gene-gene and gene-environment interactions that are pertinent to this challenging field.

Asunto(s)

Asma/genética , Clonación Molecular , Ambiente , Variación Genética , Humanos

Asunto(s)

Asma/genética , Repeticiones de Dinucleótido/genética , Exones/genética , Variación Genética/genética , Guanina/metabolismo , Regiones Promotoras Genéticas/genética , Timina/metabolismo , Transactivadores/genética , Alelos , Línea Celular Tumoral , ADN de Neoplasias/genética , ADN de Neoplasias/metabolismo , Fosfatos de Dinucleósidos/genética , Repeticiones de Dinucleótido/fisiología , Guanina/fisiología , Humanos , Células Jurkat , Proteínas Nucleares/metabolismo , Fenotipo , Polimorfismo Genético/genética , Regiones Promotoras Genéticas/fisiología , Factor de Transcripción STAT6 , Timina/fisiología , Reino Unido/epidemiología

RESUMEN

The interleukin-4 (IL-4) splice variant (IL-4delta2) is known to antagonize many biological activities of IL-4, and this challenges our understanding of the role of IL-4 in asthma. Studies that have used nonspecific antibodies, probes, and/or primers to quantify IL-4 in clinical samples would not have distinguished the expression of IL-4 from IL-4delta2. This is the first study to examine patients with chronic asthma and atopy for IL-4delta2 mRNA in their peripheral blood mononuclear cells without antigen stimulation, using a quantitative nested reverse-transcription polymerase chain reaction (RT-PCR) protocol. The median IL-4 mRNA copy number in cells from the patients with asthma was 2.8 logs higher than in a comparator group of patients with tuberculosis (p = 0.0005) and 4.5 logs higher (p = 0.0004) than in healthy control subjects. In contrast, IL-4delta2 expression in cells from patients with asthma was similar to that seen in cells from patients with tuberculosis. Hence, the median ratio of IL-4 to IL-4delta2 was 500-fold higher in the patients with asthma when compared with either patients with tuberculosis or healthy control subjects. The relative expression of IL-4 and IL-4delta2 may be a reason for the functional diversity of Th2 cells in different clinical conditions, and a hitherto unexplored mechanism for the pulmonary pathology in patients with atopic asthma.

Asunto(s)

Asma/inmunología , Interleucina-4/sangre , Interleucina-4/genética , Adolescente , Adulto , Anciano , Asma/sangre , Asma/etiología , Interpretación Estadística de Datos , Femenino , Expresión Génica , Humanos , Masculino , Persona de Mediana Edad , ARN Mensajero/análisis , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Tuberculosis Pulmonar/sangre

RESUMEN

Whole genome scan analyses have revealed that chromosomal region 3p21-24, which contains a gene cluster of CC chemokine receptors such as CCR3, is possibly linked to asthma. Because CCR3 ligands play a pivotal role in the selective recruitment and activation of inflammatory cells in the asthmatic airway, the authors examined whether there is any association between asthma and the CCR3 gene polymorphisms. Three polymorphisms were identified using the single stranded conformational polymorphism method in Japanese (Asian) and British (Caucasian) subjects; one silent mutation T51C and two missense mutations G824A and T971C. These polymorphisms were examined in 391 Japanese subjects (210 asthmatics and 181 nonasthmatic controls) and 234 British subjects (142 asthmatics and 92 nonasthmatic controls). Asthma diagnosis was based on episodic symptoms, documented wheeze, and the presence of reversible airflow limitation. CCR3 T51C demonstrated a significant association with the diagnosis of asthma in the British population (odds ratio 2.35, p<0.01), but not in the Japanese population. Multiple logistic regression analysis also showed that CCR3 T51C was associated with asthma (odds ratio 2.83, p < 0.02), independent of atopic phenotypes such as high levels of total or house dust mite-specific immunoglobulin-E in serum. In conclusion, a significant association between asthma and CCR3 T51C polymorphism localized on chromosome 3p21 was found.

Asunto(s)

Asma/genética , Polimorfismo Genético , Receptores de Quimiocina/genética , Alelos , Pueblo Asiatico/genética , Asma/inmunología , Genética de Población , Humanos , Hipersensibilidad Inmediata/complicaciones , Hipersensibilidad Inmediata/diagnóstico , Japón , Mutación , Mutación Missense , Polimorfismo de Longitud del Fragmento de Restricción , Polimorfismo Conformacional Retorcido-Simple , Receptores CCR3 , Reino Unido , Población Blanca/genética

Asunto(s)

Hipersensibilidad/inmunología , Interleucina-13/genética , Interleucina-4/genética , Receptores de Interleucina/genética , Humanos , Polimorfismo Genético , Polimorfismo de Nucleótido Simple

Asunto(s)

Proteínas Portadoras/genética , Proteínas de Transporte de Catión , Variación Genética , Proteínas de la Membrana/genética , Tuberculosis Pulmonar/genética , Adulto , Anciano , Femenino , Predisposición Genética a la Enfermedad , Humanos , Japón/epidemiología , Desequilibrio de Ligamiento , Masculino , Persona de Mediana Edad , Tuberculosis Pulmonar/diagnóstico , Tuberculosis Pulmonar/epidemiología

Asunto(s)

Asma/genética , Variación Genética , Transactivadores/genética , Inglaterra , Predisposición Genética a la Enfermedad , Humanos , Japón , Factor de Transcripción STAT6

RESUMEN

Asthma and atopy show epidemiological association and are biologically linked by T-helper type 2 (T(h)2) cytokine-driven inflammatory mechanisms. IL-4 operates through the IL-4 receptor (IL-4R, a heterodimer of IL-4Ralpha and either gammac or IL-13Ralpha1) and IL-13 operates through IL-13R (a heterodimer of IL-4Ralpha and IL-13Ralpha1) to promote IgE synthesis and IgE-based mucosal inflammation which typify atopy. Recent animal model data suggest that IL-13 is a central cytokine in promoting asthma, through the stimulation of bronchial epithelial mucus secretion and smooth muscle hyper-reactivity. We investigated the role of common genetic variants of IL-13 and IL-13Ralpha1 in human asthma, considering IgE levels. A novel variant of human IL-13, Gln110Arg, on chromosome 5q31, associated with asthma rather than IgE levels in case-control populations from Britain and Japan [peak odds ratio (OR) = 2.31, 95% CI 1.33-4.00]; the variant also predicted asthma and higher serum IL-13 levels in a general, Japanese paediatric population. Immunohistochemistry demonstrated that both subunits of IL-13R are prominently expressed in bronchial epithelium and smooth muscle from asthmatic subjects. Detailed molecular modelling analyses indicate that residue 110 of IL-13, the site of the charge-modifying variants Arg and Gln, is important in the internal constitution of the ligand and crucial in ligand-receptor interaction. A non-coding variant of IL-13Ralpha1, A1398G, on chromosome Xq13, associated primarily with high IgE levels (OR = 3. 38 in males, 1.10 in females) rather than asthma. Thus, certain variants of IL-13 signalling are likely to be important promoters of human asthma; detailed functional analysis of their actions is needed.

Asunto(s)

Asma/genética , Asma/inmunología , Hipersensibilidad Inmediata/genética , Hipersensibilidad Inmediata/inmunología , Interleucina-13/genética , Transducción de Señal/inmunología , Adulto , Sustitución de Aminoácidos/genética , Asma/patología , Bronquios/química , Bronquios/inmunología , Estudios de Casos y Controles , Niño , Simulación por Computador , Variación Genética , Glutamina/genética , Humanos , Hipersensibilidad Inmediata/patología , Inmunohistoquímica , Interleucina-13/sangre , Interleucina-13/fisiología , Subunidad alfa1 del Receptor de Interleucina-13 , Interleucina-4/genética , Interleucina-4/fisiología , Modelos Moleculares , Receptores de Interleucina/genética , Receptores de Interleucina-13 , Transducción de Señal/genética

RESUMEN

The platelet-activating factor (PAF) represents a phospholipid with complex biological functions, including involvement in inflammatory processes. The degrading enzyme PAF acetylhydrolase (PAFAH) represents a candidate for asthma and other atopic diseases. Two loss-of-function mutations of PAFAH are associated with severe asthma in Japanese individuals. Our aim was to look for further PAFAH variants in white populations, their possible association with atopic and asthmatic phenotypes, and their functional importance. We picked up three common variants in the PAFAH gene: Arg92His (exon 4), Ile198Thr (exon 7), and Ala379Val (exon 11). The known loss-of-function mutations were not seen. The variant allele Thr198 was found to be highly associated with total IgE concentrations in an atopic population (P=.009) and with "atopic asthma" in an asthmatic population (P=.008). The variant allele Val379 was found to be highly associated with "specific sensitization" in the atopic population (P=.002) and with "asthma" in the asthmatic population (P=.003). By use of recombinant PAFAH enzymes, the variant Val379 showed increased (14 microM) and Thr198 markedly increased (42 microM) KM values compared to the wild type (7 microM); furthermore, Vmax of Val379 was highly increased (132%). Thr198 and Val379 influence plasmatic PAFAH toward lower substrate affinities and therefore are very likely to prolong the activities of PAF. At the same time, they are associated with an increased risk to develop asthma and atopy. Thus, two PAFAH variants seem to play a key role in atopic and asthmatic processes in Caucasian populations.

Asunto(s)

Sustitución de Aminoácidos/genética , Asma/genética , Hipersensibilidad Inmediata/genética , Mutación/genética , Fosfolipasas A/genética , Fosfolipasas A/metabolismo , 1-Alquil-2-acetilglicerofosfocolina Esterasa , Adolescente , Adulto , Alelos , Asma/enzimología , Asma/inmunología , Estudios de Casos y Controles , Catálisis , Niño , Exones/genética , Frecuencia de los Genes/genética , Predisposición Genética a la Enfermedad/genética , Variación Genética/genética , Humanos , Hipersensibilidad Inmediata/enzimología , Hipersensibilidad Inmediata/inmunología , Inmunoglobulina E/análisis , Cinética , Desequilibrio de Ligamiento/genética , Fenotipo , Fosfolipasas A/antagonistas & inhibidores , Fosfolipasas A/aislamiento & purificación , Polimorfismo Genético/genética , Proteínas Recombinantes/antagonistas & inhibidores , Proteínas Recombinantes/genética , Proteínas Recombinantes/aislamiento & purificación , Proteínas Recombinantes/metabolismo , Población Blanca/genética

RESUMEN

Nitric oxide (NO) gas concentrations are higher in expired air in asthmatics. NO is synthesized by three isoforms of NO synthase (NOS) encoded by three distinct genes, NOS1, NOS2, and NOS3. Genome-wide searches have identified linkages to asthma on chromosomes 7, 12, and 17 where these three genes are localized. No association study, however, has been reported to date. To test whether variants of NOS1, NOS2, and NOS3 relate to asthma, a genetic association study was conducted in a British population (n = 300). Intragenic microsatellite variants of NOS1 were significantly associated with asthma [odds ratio (OR) = 2.08, 95% CI: 1.20-3.57 (95% CI), P = 0.008 (Pc = 0.048)], but not with IgE levels. Neither NOS2 nor NOS3 variants showed any association with asthma nor IgE levels. These findings suggest that NOS1 variants may be a significant contributor to asthma in a British population.

Asunto(s)

Asma/enzimología , Asma/genética , Variación Genética , Óxido Nítrico Sintasa/genética , Alelos , Asma/inmunología , Mapeo Cromosómico , Cromosomas Humanos Par 12 , Cromosomas Humanos Par 17 , Cromosomas Humanos Par 7 , Humanos , Inmunoglobulina E/sangre , Intrones , Repeticiones de Microsatélite , Repeticiones de Minisatélite , Proteínas del Tejido Nervioso/genética , Óxido Nítrico Sintasa de Tipo I , Óxido Nítrico Sintasa de Tipo II , Óxido Nítrico Sintasa de Tipo III , Regiones Promotoras Genéticas , Valores de Referencia , Reino Unido

Asunto(s)

Cromosomas Humanos Par 5 , Inmunoglobulina E/sangre , Receptores de Lipopolisacáridos/genética , Alelos , Asma/genética , Dendritas/metabolismo , Regulación de la Expresión Génica , Ligamiento Genético , Humanos , Hipersensibilidad Inmediata/genética , Japón , Polimorfismo Genético , Regiones Promotoras Genéticas , Reino Unido

RESUMEN

Atopy is an immune disorder in which a Th2 dominant mechanism leads to high IgE levels and the clinical disorder asthma. It has been postulated that the Th1 cytokine IFNgamma, acting through its heterodimeric receptors, IFNgammaR1 and IFNgammaR2, in the induction/proliferation of Th1 cells, might suppress the Th2 responses that may underlie atopic asthma. However, neither murine nor human variants of IFNgamma associate with atopy. Several dysfunctional mutations have been identified in IFNgamma receptor genes (IFNGR1 and IFNGR2) in relation to severe and selective infections with poorly pathogenic organisms. However, little is known about common polymorphisms and their functional role in atopy. To test whether such variants of IFNGR1 and IFNGR2 relate to atopic asthma, we conducted a genetic association study in both British (n = 300) and Japanese (n = 200) populations. An intronic variant of IFNGR1 showed marginal association with total serum IgE levels in the British population compared with those with total IgE levels <30 IU/ml and those with >120-500 IU/ml [odds ratio = 2.00 (95% CI 1. 00-4.07), P = 0.048]. A coding variant, Gln64Arg of the IFNGR2, also associated with total serum IgE levels in the British population [chi(2) = 5.08, P = 0.024]. Further genetic and functional analyses are needed to clarify the role of variants of IFNgamma receptor genes in atopic immune disorder among different ethnic groups.

Asunto(s)

Asma/genética , Variación Genética , Hipersensibilidad Inmediata/genética , Inmunoglobulina E/sangre , Receptores de Interferón/genética , Asma/etiología , Genotipo , Hipersensibilidad Inmediata/etiología , Interferón gamma/metabolismo , Japón , Receptores de Interferón/metabolismo , Células TH1 , Células Th2 , Reino Unido , Receptor de Interferón gamma

RESUMEN

Asthma is a complex syndrome in which bronchial inflammation and smooth muscle hyperactivity lead to labile airflow obstruction. The commonest form of asthma is that due to atopy, which is an immune disorder where production of IgE to inhaled antigens leads to bronchial mucosal inflammation. The ultimate origins of asthma are interactive environmental and genetic factors. The genetics is acknowledged to be heterogeneous, and one chromosomal region of interest and controversy has been 11q13. To clarify the nature of the chromosome 11q13 effect in atopy and asthma, we conducted a genetic association study in subjects with marked atopic asthma and matched controls, which incorporated the study of 13 genetic variants over a distance of 10-12 cM and which took account of detailed immune and clinical phenotyping. Association with high IgE levels was limited to the interval flanked by D11S1335 and CD20 in a 0.8-Mb interval and was greatest for variants of Fc epsilonRIbeta and HTm4; these variants also associated with asthma (recurrent wheeze with labile airflow obstruction and need for regular inhaler treatment). At the more telomeric marker, D11S480, variants associated with asthma, but not with high IgE levels. The data might support the possibility of multiple loci relevant to atopic asthma on chromosome 11q13.

Asunto(s)

Asma/genética , Cromosomas Humanos Par 11 , Alelos , Estudios de Casos y Controles , Mapeo Cromosómico , Femenino , Frecuencia de los Genes , Humanos , Repeticiones de Microsatélite/genética , Polimorfismo Genético

RESUMEN

Endothelin-1 (ET-1) is a 21 amino acid peptide released from several types of bronchial cells. It operates through two types of receptors, type A(ET-RA) and type B(ET-RB) and has various activities in the pathophysiology of atopic asthma. These genes are localised on different chromosomes where genome-wide searches have identified linkage for atopic asthma, thus supporting the candidacy of ET-1 and its receptors for atopic asthma. A genetic association study was performed with variants of these three genes in both British (n = 300) and Japanese populations (n = 200). No significant association was found between variants of EDN1 and EDNRB genes, and atopic asthma in either population. However, variants of EDNRA gene showed a marginal association with atopy [odds = 0.39(95% CI: 0.17-0.89), p = 0.022, Pc = 0.066], especially with antigen specific IgE levels [odds = 0.31 (95% CI: 0.20-0.77), p = 0.006, Pc = 0.018] in the British population. These findings suggest that EDNRA is a major candidate locus for atopy on chromosome 4.

Asunto(s)

Asma/genética , Endotelina-1/genética , Variación Genética/genética , Receptores de Endotelina/genética , Especificidad de Anticuerpos , Asma/inmunología , Cromosomas Humanos Par 4/genética , Inglaterra , Femenino , Frecuencia de los Genes , Ligamiento Genético/genética , Genotipo , Humanos , Inmunoglobulina E/análisis , Inmunoglobulina E/inmunología , Japón , Oportunidad Relativa , Fenotipo , Embarazo , Isoformas de Proteínas/genética , Receptor de Endotelina A , Receptor de Endotelina B

RESUMEN

Two variants of the IL-4R alpha-chain (IL-4Ralpha) gene have been recently identified in association with different atopic disorders. To clarify the etiological relationship between the two variants, we analyzed responsiveness to IL-4 of transfectants with four kinds of IL-4Ralpha carrying either Val or Ile at 50 and either Gln or Arg at 551. The substitution of Ile for Val augmented STAT6 activation, proliferation, and transcription activity of the Iepsilon promoter by IL-4, whereas that of Arg for Gln did not change these IL-4 signals. Arg551 was not associated with atopic asthma in the Japanese population. CD23 expression and IgE synthesis by IL-4 were augmented in Ile50-bearing PBMC, compared with those bearing Val50. Taken together, substitution of Arg551 does not enhance the IL-4 signal for generation of germline epsilon transcript, whereas the substitution of Ile50 contributes to enhancement of IgE synthesis.

Asunto(s)

Variación Genética , Inmunoglobulina E/biosíntesis , Receptores de Interleucina-4/genética , Sustitución de Aminoácidos , Animales , Linfocitos B/inmunología , Linfocitos B/metabolismo , Secuencia de Bases , Línea Celular , Humanos , Hipersensibilidad Inmediata/genética , Hipersensibilidad Inmediata/inmunología , Ratones , Mutagénesis Sitio-Dirigida , Sondas de Oligonucleótidos/genética , Regiones Promotoras Genéticas , Conformación Proteica , Receptores de IgE/metabolismo , Receptores de Interleucina-4/química , Receptores de Interleucina-4/metabolismo , Proteínas Recombinantes/química , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Factor de Transcripción STAT6 , Transducción de Señal , Transactivadores/metabolismo , Transfección

Asunto(s)

Asma/genética , Proteínas de Unión al ADN/genética , Dermatitis Atópica/genética , Proteínas Proto-Oncogénicas/genética , Factores de Transcripción/genética , Asma/etiología , Asma/inmunología , Dermatitis Atópica/etiología , Dermatitis Atópica/inmunología , Variación Genética , Humanos , Inmunoglobulina E/metabolismo , Proteínas Proto-Oncogénicas c-bcl-6

Asunto(s)

Asma/genética , Peptidil-Dipeptidasa A/genética , Polimorfismo Genético , Humanos , Japón , Reino Unido

RESUMEN

The gene encoding Clara cell-derived inflammatory molecule CC16 has been cited as a candidate gene for atopic asthma on chromosome 1lq13. A genetic association study was performed with variants of the CC16 gene on chromosome 1lq13 in relation to asthma in British (n=275) and Japanese (n=300) populations. No significant association was found between asthma and CC16 genotypes, irrespective of atopic status in these two populations. These data suggest that CC16 might not be the major locus for asthma on 11q13.

Asunto(s)

Asma/genética , Cromosomas Humanos Par 11 , Variación Genética , Proteínas/genética , Uteroglobina , Asma/clasificación , Mapeo Cromosómico , Genotipo , Humanos , Japón , Oportunidad Relativa , Reacción en Cadena de la Polimerasa , Valores de Referencia , Medición de Riesgo , Reino Unido

Asunto(s)

Asma/inmunología , Inmunoglobulina E/biosíntesis , Isoleucina/inmunología , Receptores de Interleucina-4/inmunología , Regulación hacia Arriba , Valina/inmunología , Sustitución de Aminoácidos , Animales , Asma/complicaciones , Humanos , Hipersensibilidad/complicaciones , Hipersensibilidad/inmunología , Isoleucina/genética , Ratones , Ratones Endogámicos BALB C , Receptores de Interleucina-4/genética , Valina/genética